JPND is implementing the priorities identified in its research strategy through a range of large-scale programmatic initiatives.

Until now, JPND has launched Joint Transnational Calls in Quarter 4 (Oct-Dec) each year to address high priority areas in neurodegenerative disease research*.

A pre-call announcement with indicative call topics is expected in early Quarter 4 (October) each year.

* The JPND diseases are:
Alzheimer’s disease (AD) and other dementias, Parkinson’s disease (PD) and PD-related disorders, Prion disease, Motor neurone diseases (MND), Huntington’s Disease (HD), Spinocerebellar ataxia (SCA), Spinal muscular atrophy (SMA)